|Year : 2016 | Volume
| Issue : 4 | Page : 252-254
Corticosteroids in dentistry
Rishu Bhanot1, Jyoti Mago2
1 Department of Medicine, DMC and Hospital, Ludhiana, Punjab, India
2 Department of Oral Medicine and Radiology, SKSS Dental College and Hospital, Ludhiana, Punjab, India
|Date of Web Publication||27-Dec-2016|
Department of Medicine, DMC and Hospital, Ludhiana, Punjab
Source of Support: None, Conflict of Interest: None
Steroids are one of the widely used drugs in dentistry. These are immunosuppressive agents. The reason for its use is its anti-inflammatory as well as immunosuppressive properties. Corticosteroids have revolutionized the management of several disabling conditions, but its use in term of dosage is inappropriate. The current review highlights its uses, contraindications, side-effects as well as a guideline for its use in dentistry.
Keywords: Adrenal insufficiency, anti-inflammatory, corticosteroid, immunosuppressive
|How to cite this article:|
Bhanot R, Mago J. Corticosteroids in dentistry. Indian J Dent Sci 2016;8:252-4
Steroids are the substances that are naturally produced in our body. These are one of the widely prescribed drugs in both medical and dental sciences. Commonly used steroids are hydrocortisone, dexamethasone, methyl prednisolone, prednisolone, etc. Dental patients with a history of corticosteroid use may require special consideration before receiving any dental treatment. Currently, the misuse of steroids is its overdosage as it is prescribed even before minor dental procedures. The risks associated with excess glucocorticoid administration are relatively small. These includes impaired electrolyte balance and hypertension. The current review emphasizes on the uses and guidelines of use of corticosteroid in dentistry.
| Uses and Effects of Steroid in Dentistry|| |
Steroids have shown its effects on root resorption. In intracanal medicaments such as ledermix paste which reduces pulpal inflammation as well as root resorption. Further, zinc oxide eugenol along with steroids is also used as root canal sealer. In cavity liners, when steroid is mixed with chloramphenicol and gum caphor to reduce mainly postoperative thermal sensitivity.
It is reported that the upon treatment with hydrocortisone at a dose of 10 mg/kg/day for 7 days on rats followed by observed for 20 h; the teeth showed a lower amount of tooth movement. Hence, it is essential that the patients are reviewed of their prior history of corticosteroids use.
Steroids are used after oral surgical procedures to limit postoperative inflammation. In 1974, Hooley and Hohl elaborated the use of steroid in the prevention of postoperative edema. He further concluded that topical use of steroid helps to prevent ulceration and excoriation which results during retraction during surgery over the lips and corners of the mouth.
In the treatment of various diseases as summarized.
Oral submucous fibrosis
Topical application of steroid applied over ulcerative or painful mucosa. The anti-inflammatory property of steroid shows a direct healing action on the mucosal patch.
Oral lichen planus
A gingival tray can also be used to deliver 0.05% clobetasol propionate with 100,000 IU/ml of nystatin in orabase. Around 3–5 min application of this mixture daily appears to be effective in controlling erosive lichen planus.
Early therapy begins with systemic prednisone (0.5–1.0 mg/kg/day) or pulse methylprednisolone (1 mg/kg/day for 3 days). Intravenous pulsed dose methylprednisolone (3 consecutive daily infusions of 20–30 mg/kg to a maximum of 500 mg given over 2–3 h) is reported, with the suggestion that this approach is superior to oral prednisone because it imparts the benefit when treatment is administered as early as possible in the progression of the cutaneous insult.
Systemic steroids with other immunosuppressive agents are used. Pulse therapy is most commonly used. Each pulse is not standardized. 500–1000 mg prednisolone or 100–200 dexamethasone is given for each pulse.
Bullous and mucous membrane pemphigoid
The mainstay of the treatment of pemphigoid is a moderate dose of corticosteroid. However, in severe cases, steroid-sparing agents are used. This includes clobetasol propionate 20–40 mg daily dose.
Prednisolone 60–80 mg daily during 1st 5 days and taper over next 5 days.
Central giant cell granuloma
Intracellular corticosteroid injections are used for nonsurgical treatment. Topically, triamcinolone acetonide can also be given as it suppresses an angiogenic component of the lesion.
Post herpetic neuralgia
The systemic steroid is used to reduce the pain in these patients.
Melkersson Rosenthal Syndrome
Due to anti-inflammatory action of steroid, it is used to reduce swelling and persistent edema. Short courses are preferred. Prednisolone in dose 1–1.5 mg/kg/day is given mainly. Tapering can be done further over 3–6 weeks depending on the severity as well as response.
| Guideline for Dental Use|| |
Current evidence reveals that the majority of patients with adrenal insufficiency can undergo routine, nonsurgical dental treatment without the need for supplemental glucocorticoids., This conclusion is supported by the fact that these dental procedures do not stimulate cortisol production at levels comparable to those oral surgical procedures, and local anesthetic blocks neural stress pathways required for adrenocorticotropic hormone secretion.
For patients undergoing general anesthesia for minor surgery 100 mg hydrocortisone intramuscularly should be administered and the usual glucocorticoid medications maintained. For major surgery 100 mg hydrocortisone delivered as a bolus preoperatively followed by 50 mg 8-hourly for 48 h is adequate.
The major controversy resides for the patients who are undergoing any oral surgical procedures and had discontinued steroids recently. These are prescribed with supplemental steroid therapy. A conservative approach remains to wait 2 weeks for the normal adrenal function to return before performing elective oral surgical procedures.,, However, this conservative waiting period is not required for patients who are receiving 30 mg of hydrocortisone (that is, 5 mg of prednisone) or less per day.
| Contraindications of Steroids|| |
Steroids may exacerbate the response in the following conditions. Therefore, these are contraindicated. In patients with:
- Primary bacterial infection
- Peptic ulcer
- Diabetes mellitus
- Herpes simplex infections
- Congestive heart failure
- Renal failure.
| Sideeffects|| |
Sideeffects depend on duration for which steroids are given, dosage of the drug as well as approach it is used.
In patients, suffering from primary hyperaldosteronism secondary to an adrenal adenoma and in patients treated with potent mineralocorticoids, it may cause hypokalemic alkalosis, edema as well as hypertension.
Other side effects includes Cushing's habitus, skin atrophy, precipitation of diabetic myopathy, susceptibility to infection, delayed healing of wounds, peptic ulcers, osteoporosis, osteonecrosis, ophthalmic complications, growth retardation, fetal abnormalities, central nervous system complications, suppression of hypothalamic-pituitary-adrenal axis, effects on reproductive system, hyperlipidemia, weight gain, atherosclerosis, hypertension, malignancy.
This approach causes adverse effects, such as skin atrophy, hypopigmentation contact dermatitis, oral thrush, subcutaneous fat wasting, and cushingoid effect.
These include oropharyngeal candidiasis, dysphonia, reflex cough, bronchospasm, pharyngitis.
This may lead to mucosal atrophy.
| Minimize the Effects of Steroid Therapy|| |
Probiotics play a crucial role in minimizing the effects of candidiasis when the patient is under steroid therapy. Probiotics act in three-ways. First, it inhibits pathogenic enteric bacteria. Second, it improves epithelial and mucosal barrier function by enhancing mucus production, increasing barrier integrity and by producing short chain fatty acids. Third, it alters immune regulation by stimulating secretory immunoglobulin a production, decreasing tumor necrosis factor expression, by inducing interleukin-10.
| Conclusion|| |
Corticosteroids are regarded as double-edged sword to the patients. Despite its various advantages, they also have severe side-effects. These drugs are one of the most misused drugs in the form of dosage. The current article highlights its various uses, side-effects, and contraindications in the oral and maxillofacial region as well as a guideline for its use in dentistry.
Dr. Rajesh Bhanot, Principal and HOD, Department of Prosthodontics, SKSS Dental College and Hospital, Sarabha, Ludhiana, Punjab, India.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Hooley JR, Hohl TH. Use of steroids in the prevention of some complications after traumatic oral surgery. J Oral Surg 1974;32:864-6.
Swingle WW, Remington JW, Drill VS, Kleinberg W. Differences among adrenal steroids with respect to their efficacy in protecting the adrenalectomized dog against circulatory failure. Am J Physiol 1942;136:567-76.
Sambandam V, Neelakantan P. Steroids in dentistry – A review. Int J Pharm Sci Rev Res 2013;22:240-5.
Saravanan T, Subha M, Prem P, Venkatesh A. Corticosteroids-its role in oral mucosal lesions. Int J Pharm Bio Sci 2014;5:439-46.
Borle RM, Borle SR. Management of oral submucous fibrosis: A conservative approach. J Oral Maxillofac Surg 1991;49:788-91.
Bernard P, Charneux J. Bullous pemphigoid: A review. Ann Dermatol Venereol 2011;138:173-81.
Manson SC, Brown RE, Cerulli A, Vidaurre CF. The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med 2009;103:975-94.
Martinez AE, Atherton DJ. High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme. Pediatr Dermatol 2000;17:87-90.
Kallali B, Singh K, Thaker V. Corticosteroids in dentistry. JIAOMR 2011;23:128-31.
Baker PR. Diagnosis and management of Bell's palsy. Oral Maxillofac Surg Clin North Am 2000;12:303-8.
Ferretti C, Muthray E. Management of central giant cell granuloma of mandible using intralesional corticosteroids: Case report and review of literature. J Oral Maxillofac Surg 2011;69:2824-9.
Rogers RS 3rd
. Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin 1996;14:371-9.
Bromberg JS, Baliga P, Cofer JB, Rajagopalan PR, Friedman RJ. Stress steroids are not required for patients receiving a renal allograft and undergoing operation. J Am Coll Surg 1995;180:532-6.
Friedman RJ, Schiff CF, Bromberg JS. Use of supplemental steroids in patients having orthopaedic operations. J Bone Joint Surg Am 1995;77:1801-6.
Miller CS, Dembo JB, Falace DA, Kaplan AL. Salivary cortisol response to dental treatment of varying stress. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:436-41.
Miller CS, Little JW, Falace DA. Supplemental corticosteroids for dental patients with adrenal insufficiency reconsideration of the problem. JADA 2001;132:570-1579.
Gibson N, Ferguson JW. Steroid cover for dental patients on long-term steroid medication: Proposed clinical guidelines based upon a critical review of the literature. Br Dent J 2004;197:681-5.
Lightner E, Johnson H, Corrigan J. Studies on the length of adrenal gland suppression following intermittent, short-term adrenal steroid therapy. West Pediatr Endocrinol 1977;25:173.
Spiegel RJ, Vigersky RA, Oliff AI, Echelberger CK, Bruton J, Poplack DG. Adrenal suppression after short-term corticosteroid therapy. Lancet 1979;1:630-3.
Zora JA, Zimmerman D, Carey TL, O'Connell EJ, Yunginger JW. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 1986;77(1 Pt 1):9-13.
Glowniak J, Loriaux D. A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery 1997;121:123-9.
Panat SR, Upadhyay N, Khan M, Iqubal MA. Corticosteroids used in dentistry: An update. J Dent Sci Oral Rehabil 2014;5:89-92.
Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 2006;100:1307-17.
Thongprasom K, Dhanuthai K. Steriods in the treatment of lichen planus: A review. J Oral Sci 2008;50:377-85.
Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-33.